Business ❯Pharmaceuticals

Research and Development

Clinical Trials Investment Specialty Medicines Global Operations KarXT Biologics Cell Therapy Partnerships Natural Products

AstraZeneca Deepens China Pact With $5.2 Billion CSPC Research Collaboration

AstraZeneca’s partnership with CSPC taps AI to advance chronic disease candidates against a backdrop of ongoing Chinese regulatory scrutiny.

Roche Commits $700M to North Carolina Biologics Facility as Part of $50B U.S. Expansion

Boehringer Ingelheim Reports Strong 2024 Growth and Prepares for New Product Launches in 2025

AstraZeneca Announces $2.5 Billion Beijing R&D Hub to Bolster China Presence

Oyster Blood Shows Potential in Combating Antibiotic-Resistant Superbugs

Bristol Myers Squibb Acquires Karuna Therapeutics in $14 Billion Deal